For July 2023, we focus our attention on the Adeno-Associated Virus serotype 9 (AAV9) as the 'Clover...
For June 2023, we draw your attention to the Endothelin A Receptor (ETAR) as the 'Clovertex Drug Tar...
For May 2023, we're spotlighting the Glucagon-Like Peptide-2 Receptor (GLP2R) as the 'Clovertex Drug...